Tekton Research

Founded in 2006, Tekton Research is a multi-state clinical research site network conducting Phase 1-4 clinical trials with a focus on CNS, cardiometabolic, general medicine and infectious disease. We partner with sponsors, CROs, and biopharma to accelerate the development of new therapies while maintaining a strong commitment to patient-centered care. Led by a team of seasoned clinical research professionals and nationally recognized key opinion leaders (KOLs), Tekton delivers excellence from start-up to recruitment to retention and scientific rigor for trials of any size or complexity. With 25 sites across 8 states, we have conducted 900+ trials across Tekton’s core therapeutic areas: 🧠 CNS/Neurology (epilepsy, migraines, neurodegenerative & movement disorders) 🫀 Cardiometabolic Diseases (T1/2 Diabetes, Obesity, Lipids, Hypertension, Thyroid Disorders, NASH/MASH) 🦴 Rheumatology (rheumatoid arthritis, osteoporosis, lupus) 🩺 General Medicine (cardiovascular, weight loss, pediatrics, dermatology, immunology, CNS, chronic ambulatory) 💉 Infectious Disease/Vaccines & Treatments: (Influenza, RSV, COVID-19, Pneumococcal, Combinations) Expertise Across Therapeutic Areas: General Medicine: 12 PIs with 330,000+ participants CNS/Neurology: 5 PIs with 76,000+ participants Cardiometabolic: 6 PIs with 67,000+ participants Rheumatology: 2 PIs with 85,000+ participants Tekton's PIs are board-certified specialists in our core therapeutic areas while bringing experience and interest in supporting studies that extend beyond their specialties.